A complex proinflammatory role for peripheral monocytes in Alzheimer's disease

Journal of Alzheimer's Disease

Volumn 38, Issue 2, 2014, Pages 403-413

  Saresella, Marina ^a   Marventano, Ivana ^a   Calabrese, Elena ^a   Piancone, Federica ^a   Rainone, Veronica ^b   Gatti, Andrea ^a   Alberoni, Margherita ^a   Nemni, Raffaello ^a   Clerici, Mario ^a,b  

^a IRCCS FONDAZIONE DON CARLO GNOCCHI   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

Alzheimer's disease; cytokines; monocytes; neuroinflammation; toll like receptors

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; CD14 ANTIGEN; CD16 ANTIGEN; CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CX3CR1; INTERLEUKIN 23; INTERLEUKIN 6; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 8; TOLL LIKE RECEPTOR 9;

ADAPTIVE IMMUNITY; AGED; ALZHEIMER DISEASE; ARTICLE; BLOOD BRAIN BARRIER; CELL CULTURE; CELL FUNCTION; CONFOCAL MICROSCOPY; CONTROLLED STUDY; FEMALE; HUMAN; INNATE IMMUNITY; MACROPHAGE; MACROPHAGE MIGRATION; MAJOR CLINICAL STUDY; MALE; MILD COGNITIVE IMPAIRMENT; MONOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ALZHEIMER'S DISEASE; CYTOKINES; MONOCYTES; NEUROINFLAMMATION; TOLL-LIKE RECEPTORS;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; CELLS, CULTURED; CYTOKINES; FEMALE; FLOW CYTOMETRY; HUMANS; MALE; MICROSCOPY, CONFOCAL; MILD COGNITIVE IMPAIRMENT; MONOCYTES; PEPTIDE FRAGMENTS; TOLL-LIKE RECEPTORS;

EID: 84889578149     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-131160     Document Type: Article

References (53)

1. Hardy J, Selkoe DJ (2002) The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics. Science 19, 353-356. (Pubitemid 34790756)
2. Monsonego A, Imitola J, Zota V, Oida T, Weiner HL (2003) Microglia-mediated nitric oxide cytotoxicity ofTcells following amyloid beta-peptide presentation to Th1 cells. J Immunol 171, 2216-2224. (Pubitemid 37025526)
3. Rogers J, Lue LF (2001) Microglial chemotaxis, activation, and phagocytosis of amyloid beta-peptide as linked phenomena in Alzheimer's disease. Neurochem Int 39, 333-340. (Pubitemid 32907397)
4. Rogers J, Strohmeyer R, Kovelowski CJ, Li R (2002) Microglia and inflammatory mechanisms in the clearance of amyloid beta peptide. Glia 2, 260-269. (Pubitemid 35337383)
5. Stalder AK, Pagenstecher A, Yu NC, Kincaid C, Chiang CS, Hobbs MV, Bloom FE, Campbell IL (1997) Lipopolysaccharide-induced IL-12 expression in the central nervous system and cultured astrocytes and microglia. J Immunol 3, 1344-1351. (Pubitemid 127484113)
6. Town T, Tan J, Mullan M (2001) CD40 signaling and Alzheimer's disease pathogenesis. Neurochem Int 39, 371-380. (Pubitemid 32907401)
7. Town T, Nikolic V, Tan J (2005) The microglial "activation" continuum: From innate to adaptive responses. J Neuroinflammation 31, 2-24.
8. Town T, Laouar Y, Pittenger C, Mori T, Szekely CA, Tan J, Duman RS, Flavell RA (2008) Blocking TGF-beta-Smad2/3 innate immune signaling mitigates Alzheimer-like pathology. Nat Med 14, 681-687. (Pubitemid 351809551)
9. Hawkes CA, McLaurin J (2009) Selective targeting of perivascular macrophages for clearance of beta-amyloid in cerebral amyloid angiopathy. Proc Natl Acad Sci USA 106, 1261-1266.
10. Tan J, Town T, Paris D, Mori T, Suo Z, Crawford F, Mattson MP, Flavell RA, Mullan M (1999) Microglial activation resulting from CD40-CD40L interaction after beta-amyloid stimulation. Science 286, 2352-2355. (Pubitemid 30016899)
11. Tan J, Town T, Saxe M, Paris D, Wu Y, Mullan M (1999) Ligation of microglial CD40 results in p44/42 mitogenactivated protein kinase-dependent TNF-alpha production that is opposed by TGF-beta 1 and IL-10. J Immunol 12, 6614-6621.
12. Tan J, Town T, Abdullah L, Wu Y, Placzek A, Small B, Kroeger J, Crawford F, Richards D, Mullan M (2002) CD45 isoform alteration in CD4+ T cells as a potential diagnostic marker of Alzheimer's disease. J Neuroimmunol 132, 164-172. (Pubitemid 35333339)
13. Townsend KP, Town T, Mori T, Lue LF, Shytle D, Sanberg PR, Morgan D, Fernandez F, Flavell RA, Tan J (2005) CD40 signaling regulates innate and adaptive activation of microglia in response to amyloid beta-peptide. Eur J Immunol 35, 901-910. (Pubitemid 40425546)
14. Feng Y, Li L, Sun XH (2011) Monocytes and Alzheimer's disease. Neurosci Bull 2, 115-122.
15. Fiala M, Lin J, Ringman J, Kermani-Arab V, Tsao G, Patel A, Lossinsky AS, Graves MC, Gustavson A, Sayre J, Sofroni E, Suarez T, Chiappelli F, BernardG(2005) Ineffective phagocytosis of amyloid-beta by macrophages of Alzheimer's disease patients. J Alzheimers Dis 3, 221-232. (Pubitemid 40917251)
16. Simard AR, Soulet D, Gowing G, Julien JP, Rivest S (2006) Bone marrow-derived microglia play a critical role in restricting senile plaque formation in Alzheimer's disease. Neuron 4, 489-502. (Pubitemid 43221886)
17. Mildner A, Schmidt H, Nitsche M, Merkler D, Hanisch UK, Mack M, Heikenwalder M, Br̈uckW, Priller J, PrinzM(2007) Microglia in the adult brain arise from Ly-6ChiCCR2+ monocytes only under defined host conditions. Nat Neurosci 12, 544-553.
18. Rezai-Zadeh K, Gate D, Gowing G, Town T (2011) Howto get from here to there: Macrophage recruitment in Alzheimer's disease. Curr Alzheimer Res 2, 156-163.
19. Hickman SE, El Khoury J (2010) Mechanisms of mononuclear phagocyte recruitment in Alzheimer's disease. CNS Neurol Disord Drug Targets 2, 168-173.
20. Ishizuka K, Kimura T, Igata-yi R, Katsuragi S, Takamatsu J, Miyakawa T (1997) Identification of monocyte chemoattractant protein-1 in senile plaques and reactive microglia of Alzheimer's disease. Psychiatry Clin Neurosci 3, 135-138. (Pubitemid 27262094)
21. Walter S, LetiembreM,LiuY, Heine H, PenkeB, HaoW, Bode B, Manietta N, Walter J, Schulz-Schuffer W, Fassbender K (2007) Role of the toll-like receptor 4 in neuroinflammation in Alzheimer's disease. Cell Physiol Biochem 6, 947-956. (Pubitemid 350059737)
22. Saresella M, Calabrese E, Marventano I, Piancone F, Gatti A, Alberoni M, Nemni R, ClericiM(2011) Increased activity of Th-17 and Th-9 lymphocytes and a skewing of the post-thymic differentiation pathway are seen in Alzheimer's disease. Brain Behav Immun 3, 539-547.
23. Saresella M, Calabrese E, Marventano I, Piancone F, Gatti A, Calvo MG, Nemni R, ClericiM(2010) PD1 negative and PD1 positiveCD4+Tregulatory cells in mild cognitive impairment and Alzheimer's disease. J Alzheimers Dis 3, 927-938.
24. Saresella M, Calabrese E, Marventano I, Piancone F, Gatti A, Farina E, Alberoni M, Clerici M (2012) A potential role for the PD1/PD-L1 pathway in the neuroinflammation of Alzheimer's disease. Neurobiol Aging 3, 11-22.
25. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (1984) Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDAWork Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34, 939-944. (Pubitemid 14076461)
26. American Psychiatric Association (1994) Diagnostic and Statistical Manual of Mental Disorders, DSM-IV-R.
27. Folstein MF, Folstein SE, McHugh PR (1975) "Mini-mental state" A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12, 189-198.
28. Hughes CP, Berg L, Danziger WL, Coben LA, Martin RL (1982) A new clinical scale for the staging of dementia. Br J Psychiatry 140, 566-572. (Pubitemid 12124384)
29. PetersenRC(2004) Mild cognitive impairment as a diagnostic entity. J Intern Med 256, 183-194. (Pubitemid 39222988)
30. Ligthart GJ, Corberand JX, Fournier C, Galanaud P, Hijmans W, Kennes B, Muller-Hermelink HK, Steinmann GG (1984) Admission criteria for immunogerontological studies in man: The SENIEUR protocol. Mech Ageing Dev 28, 47-55. (Pubitemid 15222465)
31. Speciale L, Calabrese E, Saresella M, Tinelli C, Mariani C, Sanvito L, Longhi R, Ferrante P (2007) Lymphocyte subset patterns and cytokine production in Alzheimer's disease patients. Neurobiol Aging 28, 1163-1169. (Pubitemid 46810052)
32. Bolte S, Cordelìeres FP (2006) A guided tour into subcellular colocalization analysis in light microscopy. J Microsc 224, 213-232. (Pubitemid 46010930)
33. French AP, Mills S, Swarup R, Bennett MJ, Pridmore TP (2008) Colocalization of fluorescent markers in confocal microscope images of plant cells. Nat Protoc 4, 619-628. (Pubitemid 351516758)
34. Manders EMM (1997) Chromatic shift in multicolour confocal microscopy. J Microsc 185, 321-328. (Pubitemid 27163310)
35. Fiala M, Liu PT, Espinosa-Jeffrey A, Rosenthal MJ, Bernard G, Ringman JM, Sayre J, Zhang L, Zaghi J, Dejbakhsh S, Chiang B, Hui J, Mahanian M, Baghaee A, Hong P, Cashman J (2007) Innate immunity and transcription of MGAT-III and Toll-like receptors in Alzheimer's disease patients are improved by bisdemethoxycurcumin. Proc Natl Acad Sci USA 104, 12849-12854. (Pubitemid 47255243)
36. Zaghi J, Goldenson B, Inayathullah M, Lossinsky AS, Masoumi A, Avagyan H, Mahanian M, Bernas M, Weinand M, Rosenthal MJ, Espinosa-Jeffrey A, de Vellis J, Teplow DB, Fiala M (2009) Alzheimer disease macrophages shuttle amyloid-beta from neurons to vessels, contributing to amyloid angiopathy. Acta Neuropathol 117, 111-124.
37. Avagyan H, Goldenson B, Tse E, Masoumi A, Porter V, Wiedau-Pazos M, Sayre J, Ong R, Mahanian M, Koo P, Bae S, Micic M, Liu PT, Rosenthal MJ, Fiala M (2009) Immune blood biomarkers of Alzheimer disease patients. J Neuroimmunol 2, 67-72.
38. Iwasaki A, Medzhitov R (2004) Toll-like receptor control of the adaptive immune responses. Nat Immunol 10, 987-995. (Pubitemid 41057715)
39. Iwasaki A, MedzhitovR(2010) Regulation of adaptive immunity by the innate immune system. Science 327, 291-295.
40. Fassbender K,Walter S,K̈uhl S, Landmann R, Ishii K, Bertsch T, Stalder AK, Muehlhauser F, Liu Y, Ulmer AJ, Rivest S, Lentschat A, Gulbins E, Jucker M, Staufenbiel M, Brechtel K, Walter J, Multhaup G, Penke B, Adachi Y, Hartmann T, Beyreuther K (2004) The LPS receptor (CD14) links innate immunity with Alzheimer's disease. FASEB J 1, 203-205.
41. Malm T, Koistinaho M, Muona A, Magga J, Koistinaho J (2010) The role and therapeutic potential of monocytic cells in Alzheimer's disease. Glia 8, 889-900.
42. Liu S, Liu Y, HaoW,Wolf L, Kiliaan AJ, Penke B, R̈ube CE, Walter J, Heneka MT, Hartmann T, Menger MD, Fassbender K(2012) TLR2 is a primary receptor for Alzheimer's amyloid peptide to trigger neuroinflammatory activation. J Immunol 3, 1098-1107.
43. Langrish CL, Chen Y, Blumenschein WM, Mattson J, Basham B, Sedgwick JD, McClanahan T, Kastelein RA, Cua DJ (2005) IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J Exp Med 201, 233-240. (Pubitemid 40189432)
44. Rezai-Zadeh K, Gate D, Szekely CA, Town T (2009) Can peripheral leukocytes be used as Alzheimer's disease biomarkers Expert Rev Neurother 11, 1623-1633.
45. Saijo K, Winner B, Carson CT, Collier JG, Boyer L, Rosenfeld MG, Gage FH, GlassCK(2009)ANurr1/CoREST pathway in microglia and astrocytes protects dopaminergic neurons from inflammation-induced death. Cell 1, 47-59.
46. McCoy MK, Tansey MG (2008) TNF signaling inhibition in the CNS: Implications for normal brain function and neurodegenerative disease. J Neuroinflammation 17, 5-45.
47. Simi A, Tsakiri N,Wang P, Rothwell NJ (2007) Interleukin-1 and inflammatory neurodegeneration. Biochem Soc Trans 5, 1122-1126. (Pubitemid 350206443)
48. Glass CK, Saijo K,Winner B, MarchettoMC,GageFH(2010) Mechanisms underlying inflammation in neurodegeneration. Cell 6, 918-934.
49. Arosio B, Trabattoni D, Galimberti L, Bucciarelli P, Fasano F, Calabresi C, Cazzullo CL, Vergani C, Annoni G, ClericiM (2004) Interleukin-10 and interleukin-6 gene polymorphisms as risk factors for Alzheimer's disease. Neurobiol Aging 25, 1009-1015. (Pubitemid 38798062)
50. El Khoury J, Toft M, Hickman SE, Means TK, Terada K, Geula C, Luster AD (2007) Ccr2 deficiency impairs microglial accumulation and accelerates progression of Alzheimer-like disease. Nat Med 4, 432-438. (Pubitemid 46559828)
51. Ponomarev ED, Veremeyko T, Weiner HL (2013) MicroRNAs are universal regulators of differentiation, activation, and polarization of microglia and macrophages in normal and disease CNS. Glia 61, 91-103.
52. Shechter R, Schwartz M (2013) Harnessing monocytederived macrophages to control central nervous system pathologies: No longer 'if' but 'how'. J Pathol 229, 332-346.
53. Browne TC, McQuillan K, McManus RM, O'Reilly JA, Mills KH, Lynch MA (2013) IFN-Production by amyloid-specific Th1 cells promotes microglial activation and increases plaque burden in a mouse model of Alzheimer's disease. J Immunol 190, 2241-2251.